Nurix Therapeutics

NRIXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.650 B

$25.53 +1.23%

Close of 7 Aug 2026

Revenue

$84.0M

#2578 by revenue

Earnings

-$264.5M

Loss-making

Shares outstanding

103,781,683

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#84Supernus PharmaceuticalsSUPN$2.77B
#85AtaiBeckleyATAI$2.67B
#86Nurix TherapeuticsNRIX$2.65B
#87Trevi TherapeuticsTRVI$2.63B
#88Zai LabZLAB$2.62B

Where these numbers come from

Share counts and financials for Nurix Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.